Assembly Biosciences, Inc. Payments of Financing Costs
Assembly Biosciences, Inc. (ASMB) reported Payments of Financing Costs of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2014-05-14
- Assembly Biosciences, Inc. payments of financing costs for the quarter ending 2014-03-31 was $0.00.
- Assembly Biosciences, Inc. payments of financing costs for the quarter ending 2013-12-31 was $0.00.
- Assembly Biosciences, Inc. payments of financing costs for the quarter ending 2013-09-30 was $0.00.
- Assembly Biosciences, Inc. payments of financing costs for the quarter ending 2013-06-30 was $0.00.
- Assembly Biosciences, Inc. payments of financing costs for fiscal 2013 was $0.00.
- Assembly Biosciences, Inc. payments of financing costs for fiscal 2012 was $0.00.
- Assembly Biosciences, Inc. payments of financing costs for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- Assembly Biosciences, Inc. payments of financing costs for fiscal 2010 was $755.09K, a 887.55% increase from fiscal 2009.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month | Payments of Financing Costs 69 month | Payments of Financing Costs 72 month | Payments of Financing Costs 75 month | Payments of Financing Costs 78 month | Payments of Financing Costs 81 month | Payments of Financing Costs 84 month | Payments of Financing Costs 87 month | Payments of Financing Costs 90 month | Payments of Financing Costs 93 month | Payments of Financing Costs 96 month | Payments of Financing Costs 99 month | Payments of Financing Costs 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.43M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $1.43M 10-K · filed 2014-03-31 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.43M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.43M 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | -$57.89K derived: sum of 4 quarters · filed 2014-05-14 | $1.43M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | -$57.89K derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $1.43M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$57.89K derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 4 quarters · filed 2013-11-12 | $1.43M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | -$57.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $0.00 derived: sum of 4 quarters · filed 2013-08-09 | $1.43M 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $57.89K 10-Q · filed 2013-05-10 | $57.89K derived: sum of 2 quarters · filed 2013-05-10 | $57.89K derived: sum of 3 quarters · filed 2013-05-10 | $1.43M 10-Q · filed 2012-05-09 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | $1.43M 10-K · filed 2012-03-14 | ||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q/A 72 month − 10-Q 69 month · filed 2011-11-18 | $0.00 10-Q · filed 2012-11-13 | $1.43M 10-Q/A · filed 2011-11-18 | |||||||||||||
| 2011-06-30 | $1.43M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2010-12-31 | -$234.66K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | -$77.16K derived: sum of 2 quarters · filed 2013-03-18 | $755.09K 10-K · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | $157.50K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | $989.75K 10-Q/A · filed 2011-11-18 | ||||||||||||||
| 2010-06-30 | $832.25K 10-Q · filed 2011-08-15 | |||||||||||||||
| 2009-12-31 | $76.46K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |